DBD (Diebold Nixdorf, Incorporated) Stock Analysis - Hedge Fund Holdings
Diebold Nixdorf, Incorporated (DBD) is a publicly traded Technology sector company. As of May 21, 2026, DBD trades at $71.41 with a market cap of $2.39B and a P/E ratio of 27.98. DBD moved +4.20% today. Year to date, DBD is +9.27%; over the trailing twelve months it is +46.33%. Its 52-week range spans $34.88 to $89.05. Analyst consensus is buy with an average price target of $100.00. Rallies surfaces DBD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns DBD stock?
Hedge funds tracked by Rallies that own DBD include Panagora Asset and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Diebold Nixdorf, Incorporated.
DBD Key Metrics
Key financial metrics for DBD
Metric
Value
Price
$71.41
Market Cap
$2.39B
P/E Ratio
27.98
EPS
$2.57
Dividend Yield
0.00%
52-Week High
$89.05
52-Week Low
$34.88
Volume
2
Avg Volume
0
Revenue (TTM)
$3.81B
Net Income
$97.50M
Gross Margin
25.26%
Top Hedge Funds Holding DBD
Panagora Asset holds 14.35K shares of DBD, changed +0.00% as of Mar 31, 2026.
Mangrove Partners holds 3.01K shares of DBD, changed +0.00% as of Mar 31, 2026.
Hedge funds tracked by Rallies that own DBD include Panagora Asset and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Diebold Nixdorf, Incorporated.
Does Rallies show 13F holders for DBD?
Yes. Rallies tracks hedge fund and 13F ownership data for DBD, including fund names, share counts, latest tracked quarter, and position changes when available.
Is DBD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for DBD. It does not provide personalized investment advice.
